Cancer Risk and Surveillance in Primary Sclerosing Cholangitis

被引：42
|
作者：
Folseraas, Trine [1 ,2 ,3 ]
Boberg, Kirsten Muri [1 ,2 ,3 ]
机构：
[1] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Gastroenterol Sect, N-0424 Oslo, Norway
[2] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Norwegian PSC Res Ctr,Dept Transplantat Med, N-0424 Oslo, Norway
[3] Univ Oslo, Rikshosp, Inst Clin Med, N-0027 Oslo, Norway
来源：
CLINICS IN LIVER DISEASE | 2016年 / 20卷 / 01期
关键词：
Primary sclerosing cholangitis; Carcinoma; Dysplasia; Cholangiocarcinoma; Inflammatory bowel disease; Surveillance; Brush cytology; INFLAMMATORY-BOWEL-DISEASE; IN-SITU HYBRIDIZATION; DOSE URSODEOXYCHOLIC ACID; POPULATION-BASED COHORT; ULCERATIVE-COLITIS; LIVER-TRANSPLANTATION; COLORECTAL-CANCER; NATURAL-HISTORY; BRUSH CYTOLOGY; CLINICAL PRESENTATION;
D O I：
10.1016/j.cld.2015.08.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Primary sclerosing cholangitis (psq is a chronic, progressive disease characterized by inflammatory and fibrosing strictures of the biliary tree. PSC is associated with a high lifetime risk of hepatobiliary and colorectal cancers. The nature of the carcinogenic process in PSC is not well established. The lack of diagnostic methods for early detection and the limited therapeutic options for cholangiocarcinoma constitute a major challenge in the current handling of PSC patients. The article reviews the risk for cancer development in PSC and discusses surveillance strategies for PSC-associated cancers.
引用
收藏
页码：79 / +
页数：21
相关论文
共 50 条
  • [21] Primary sclerosing cholangitis - the Norwegian experience
    Schrumpf, Erik
    Boberg, Kirsten Muri
    Karlsen, Tom H.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (06) : 781 - 796
  • [22] Increased risk of cancer in patients with primary sclerosing cholangitis
    Aiva Lundberg Båve
    Annika Bergquist
    Matteo Bottai
    Anna Warnqvist
    Erik von Seth
    Caroline Nordenvall
    Hepatology International, 2021, 15 : 1174 - 1182
  • [23] Increased risk of cancer in patients with primary sclerosing cholangitis
    Bave, Aiva Lundberg
    Bergquist, Annika
    Bottai, Matteo
    Warnqvist, Anna
    von Seth, Erik
    Nordenvall, Caroline
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1174 - 1182
  • [24] Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis
    Liu, Ganglei
    Lin, Jingmei
    Xie, Hao
    Shen, Bo
    Stocchi, Luca
    Liu, Xiuli
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (11) : 1389 - 1396
  • [25] Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn's colitis
    Navaneethan, Udayakumar
    Rai, Tarun
    Venkatesh, Preethi G. K.
    Kiran, Ravi P.
    GASTROENTEROLOGY REPORT, 2016, 4 (03): : 226 - 231
  • [26] Management of primary sclerosing cholangitis: Current state-of-the-art
    Cancado, Guilherme Grossi Lopes
    Hirschfield, Gideon M.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (12)
  • [27] Primary sclerosing cholangitis associated with inflammatory bowel disease: an update
    Rossi, Roberta E.
    Conte, Dario
    Massironi, Sara
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (02) : 123 - 131
  • [28] Pathogenesis and clinical spectrum of primary sclerosing cholangitis
    Gidwaney, Neelam G.
    Pawa, Swati
    Das, Kiron M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (14) : 2459 - 2469
  • [29] Malignancies in Primary Sclerosing Cholangitis - A Continuing Threat
    Bonato, Giulia
    Cristoferi, Laura
    Strazzabosco, Mario
    Fabris, Luca
    DIGESTIVE DISEASES, 2015, 33 : 140 - 148
  • [30] Increased Risk of Colorectal Cancer and Dysplasia in Patients With Crohn's Colitis and Primary Sclerosing Cholangitis
    Lindstrom, Lina
    Lapidus, Annika
    Ost, Ake
    Bergquist, Annika
    DISEASES OF THE COLON & RECTUM, 2011, 54 (11) : 1392 - 1397
12345